Gesine Bejeuhr,
PhD
Director DIA
Senior Manager, Regulatory Affairs/Quality
vfa, the Association of Research-based Pharmaceutical Companies
Dr. Gesine Bejeuhr currently works for vfa, the German Association of Research-Based Pharmaceutical Companies, where she coordinates several expert groups (with a focus on regulatory affairs, production, quality, and environment), develops industry positions, and represents the association at the European level. She previously led Regulatory and Safety Intelligence for Grunenthal, and started her career as a State Inspector (for pharmacies, hospitals, and good manufacturing practices) at the national and international levels.
Dr. Bejeuhr served as Chair of the DIA Pediatric Community of the DIA Member and Volunteer Engagement Committee. She co-led the Development of Medicines for Paediatric and Elderly Populations theme for the 2012 and 2013 DIA EuroMeetings, and has been session chair for multiple DIA Annual Meetings and EuroMeetings. Additionally, Dr. Bejeuhr served for several years on the program committee for the annual DIA/European Forum for Good Clinical Practice/European Medicines Agency Paediatric Forum. During her service on the DIA Advisory Council of Europe, Dr. Bejeuhr was one of the initiators and program committee members for a series of complimentary Advisory Council of Europe workshops in Central and Eastern Europe.
Dr. Bejeuhr is a graduate of the Christian-Albrechts-University Kiel, School of Pharmacy, and earned her PhD from Rheinische Friedrich-Wilhelms-University Bonn (Germany).
Our Leadership
-
PharmD •Chair DIA
Senior Advisor R&D
Bayer AG -
MBA •Immediate Past Chair DIA
President and Chief Executive Officer
Cancer Genetics, Inc. (CGI) -
RPh •Chair-Elect DIA
Head, Product Development Medical Affairs Customer Strategy
F. Hoffmann-La Roche Ltd. -
CPA, CGMA •Secretary/Treasurer DIA
Chief Financial Officer
Katabat -
MS • Global Chief Executive
DIA
-
MD, PhD, DSc •Director DIA
Director, Deputy Qualified Person for Pharmacovigilance, Global Patient Safety
Eli Lilly and Company, Ltd. -
MPharm •Director DIA
Executive Director, Global Regulatory Policy
Merck Sharp & Dohme (Europe) Inc. -
MD •Director DIA
Chief Scientific Officer
Syneos Health -
CPA •Director DIA
Partner, Life Science Industry Practice Group, RSM US -
MD •Director DIA
Chief Medical Officer
Flagship Pioneering -
PhD •Director DIA
Senior Vice President
QIAGEN -
MD, PhD •Director DIA
Vice President and Senior Managing Director, Development & Medical Affairs, GlaxoSmithKline Japan -
PhD •Director DIA
Chairman and Chief Executive Officer
dMed Company Limited -
PharmD •Director DIA
President, R&D Design and Delivery Innovation, IQVIA
-
PharmD • Chair, Executive Committee
-
CPA • Member, Executive Committee -
MBA • Member, Executive Committee -
RPh • Member, Executive Committee -
MS • Member, Executive Committee
-
CPA • Chair, Audit Committee -
MD, PhD, DSc • Member, Audit Committee -
MPharm • Member, Audit Committee -
PharmD • Member, Audit Committee -
PharmD • Member, Audit Committee
-
PhD • Chair, Council of Regulators
Leadership Committee
Japan Pharmaceuticals and Medical Devices Agency Liaison to the DIA Board -
PhD • Council of Regulators
Leadership Committee
European Medicines Agency Liaison to the DIA Board -
MD • Council of Regulators
Leadership Committee
US Food and Drug Administration Liaison to the DIA Board -
PhD • Council of Regulators
Swissmedic Liaison to the DIA Board
-
MS • Global Chief Executive -
MS, CPA • Chief Financial Officer -
-
DIA EMEA -
PhD • Senior Vice President & Managing Director
DIA South Korea and ASEAN -
PhD • Senior Vice President & Managing Director
DIA Americas -
PhD • Senior Vice President & Managing Director
DIA Japan -
RPh, MBA • Senior Vice President & Managing Director
DIA Greater China